- call +1-201-465-4211
- email sales@mrinsights.biz
DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.
Scope of the Report:
The worldwide market for DNA Repair Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the DNA Repair Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
4SC AG
ARCAGY/ GINECO GROUP
Bristol Myers Squibb
British Columbia Cancer Agency
Cambridge University Hospitals NHS Foundation Trust
Genentech
Georgetown University
German Breast Group
GlaxoSmithKline
Jiangsu Hengrui Medicine
Johnson & Johnson
Jonsson Comprehensive Cancer Center
Karyopharm Therapeutics
KuDOS Pharmaceuticals
National Health Service
National Institutes of Health
Tesaro
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
PARP Inhibitors
Other
Market Segment by Applications, can be divided into
Oncological
Stroke
There are 15 Chapters to deeply display the global DNA Repair Drugs market.
Chapter 1, to describe DNA Repair Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of DNA Repair Drugs, with sales, revenue, and price of DNA Repair Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of DNA Repair Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, DNA Repair Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe DNA Repair Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 DNA Repair Drugs Introduction
1.2 Market Analysis by Type
1.2.1 PARP Inhibitors
1.2.2 Other
1.3 Market Analysis by Applications
1.3.1 Oncological
1.3.2 Stroke
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 4SC AG
2.1.1 Business Overview
2.1.2 DNA Repair Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 4SC AG DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 ARCAGY/ GINECO GROUP
2.2.1 Business Overview
2.2.2 DNA Repair Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bristol Myers Squibb
2.3.1 Business Overview
2.3.2 DNA Repair Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 British Columbia Cancer Agency
2.4.1 Business Overview
2.4.2 DNA Repair Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Cambridge University Hospitals NHS Foundation Trust
2.5.1 Business Overview
2.5.2 DNA Repair Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Genentech
2.6.1 Business Overview
2.6.2 DNA Repair Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Genentech DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Georgetown University
2.7.1 Business Overview
2.7.2 DNA Repair Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Georgetown University DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 German Breast Group
2.8.1 Business Overview
2.8.2 DNA Repair Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 German Breast Group DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 GlaxoSmithKline
2.9.1 Business Overview
2.9.2 DNA Repair Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Jiangsu Hengrui Medicine
2.10.1 Business Overview
2.10.2 DNA Repair Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Johnson & Johnson
2.11.1 Business Overview
2.11.2 DNA Repair Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Johnson & Johnson DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Jonsson Comprehensive Cancer Center
2.12.1 Business Overview
2.12.2 DNA Repair Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Karyopharm Therapeutics
2.13.1 Business Overview
2.13.2 DNA Repair Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 KuDOS Pharmaceuticals
2.14.1 Business Overview
2.14.2 DNA Repair Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 National Health Service
2.15.1 Business Overview
2.15.2 DNA Repair Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 National Health Service DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 National Institutes of Health
2.16.1 Business Overview
2.16.2 DNA Repair Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 National Institutes of Health DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Tesaro
2.17.1 Business Overview
2.17.2 DNA Repair Drugs Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Tesaro DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global DNA Repair Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global DNA Repair Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global DNA Repair Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 DNA Repair Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 DNA Repair Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global DNA Repair Drugs Market Analysis by Regions
4.1 Global DNA Repair Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global DNA Repair Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global DNA Repair Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America DNA Repair Drugs Sales and Growth Rate (2013-2018)
4.3 Europe DNA Repair Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific DNA Repair Drugs Sales and Growth Rate (2013-2018)
4.5 South America DNA Repair Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa DNA Repair Drugs Sales and Growth Rate (2013-2018)
5 North America DNA Repair Drugs by Countries
5.1 North America DNA Repair Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America DNA Repair Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America DNA Repair Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States DNA Repair Drugs Sales and Growth Rate (2013-2018)
5.3 Canada DNA Repair Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico DNA Repair Drugs Sales and Growth Rate (2013-2018)
6 Europe DNA Repair Drugs by Countries
6.1 Europe DNA Repair Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe DNA Repair Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe DNA Repair Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany DNA Repair Drugs Sales and Growth Rate (2013-2018)
6.3 UK DNA Repair Drugs Sales and Growth Rate (2013-2018)
6.4 France DNA Repair Drugs Sales and Growth Rate (2013-2018)
6.5 Russia DNA Repair Drugs Sales and Growth Rate (2013-2018)
6.6 Italy DNA Repair Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific DNA Repair Drugs by Countries
7.1 Asia-Pacific DNA Repair Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific DNA Repair Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific DNA Repair Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China DNA Repair Drugs Sales and Growth Rate (2013-2018)
7.3 Japan DNA Repair Drugs Sales and Growth Rate (2013-2018)
7.4 Korea DNA Repair Drugs Sales and Growth Rate (2013-2018)
7.5 India DNA Repair Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia DNA Repair Drugs Sales and Growth Rate (2013-2018)
8 South America DNA Repair Drugs by Countries
8.1 South America DNA Repair Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America DNA Repair Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America DNA Repair Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil DNA Repair Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina DNA Repair Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia DNA Repair Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa DNA Repair Drugs by Countries
9.1 Middle East and Africa DNA Repair Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa DNA Repair Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa DNA Repair Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia DNA Repair Drugs Sales and Growth Rate (2013-2018)
9.3 UAE DNA Repair Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt DNA Repair Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria DNA Repair Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa DNA Repair Drugs Sales and Growth Rate (2013-2018)
10 Global DNA Repair Drugs Market Segment by Type
10.1 Global DNA Repair Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global DNA Repair Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global DNA Repair Drugs Revenue and Market Share by Type (2013-2018)
10.2 PARP Inhibitors Sales Growth and Price
10.2.1 Global PARP Inhibitors Sales Growth (2013-2018)
10.2.2 Global PARP Inhibitors Price (2013-2018)
10.3 Other Sales Growth and Price
10.3.1 Global Other Sales Growth (2013-2018)
10.3.2 Global Other Price (2013-2018)
11 Global DNA Repair Drugs Market Segment by Application
11.1 Global DNA Repair Drugs Sales Market Share by Application (2013-2018)
11.2 Oncological Sales Growth (2013-2018)
11.3 Stroke Sales Growth (2013-2018)
12 DNA Repair Drugs Market Forecast (2018-2023)
12.1 Global DNA Repair Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 DNA Repair Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America DNA Repair Drugs Market Forecast (2018-2023)
12.2.2 Europe DNA Repair Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific DNA Repair Drugs Market Forecast (2018-2023)
12.2.4 South America DNA Repair Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa DNA Repair Drugs Market Forecast (2018-2023)
12.3 DNA Repair Drugs Market Forecast by Type (2018-2023)
12.3.1 Global DNA Repair Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global DNA Repair Drugs Market Share Forecast by Type (2018-2023)
12.4 DNA Repair Drugs Market Forecast by Application (2018-2023)
12.4.1 Global DNA Repair Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global DNA Repair Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure DNA Repair Drugs Picture
Table Product Specifications of DNA Repair Drugs
Figure Global Sales Market Share of DNA Repair Drugs by Types in 2017
Table DN
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
